| CAS No. | 871700-17-3 |
|---|---|
| MDL No. | MFCD17215075 |
| MF | C26H23FIN5O4 |
| MW | 615.40 |
| InChI Key | LIRYPHYGHXZJBZ-UHFFFAOYSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Trametinib is a pyridopyrimidine used as a dimethyl sulfoxide addition compound for treating unresectable or metastatic melanoma with BRAF V600E or V600K mutations in patients without prior BRAF inhibitor treatment. It functions as an MEK inhibitor, antineoplastic agent, anticoronaviral agent, and geroprotector. It is also an organofluorine, organoiodine compound, acetamide, ring assembly, cyclopropane, and aromatic amine.
| CAS No. | 871700-17-3 |
|---|---|
| Product Name | Trametinib |
